We also elucidated the critical role of PPP2R1B in inhibiting CRC metastasis and increasing Oxaliplatin sensitivity: it acts by regulating the MAPK/ERK signalling pathway. The gene discussed is PPP2R1B; the disease is colorectal carcinoma.